Free Trial

CME Group (CME) 10K Form and Latest SEC Filings 2026

CME Group logo
$286.82 -3.47 (-1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$288.20 +1.38 (+0.48%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest CME Group SEC Filings & Recent Activity

CME Group (NASDAQ:CME) has submitted 855+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in CME Group's financial statements. The most recent filing was a Form SCHEDULE 13G submitted on April 29, 2026.

Form 4
CME GROUP INC. Reports Ownership Change on Mar. 23, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
CME Group Files Current Report on Apr. 27, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
CME Group Files Quarterly Report on Apr. 24, 2026

The 10-Q contains CME Group's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

CME Group SEC Filing History

Browse CME Group's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/29/2026 4:50 PM
CME Group (1156375) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/27/2026 3:38 PM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2026 1:38 PM
CME Group (1156375) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2026 6:13 AM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2026 1:25 PM
CME Group (1156375) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/23/2026 3:16 PM
CME Group (1156375) Filer
Form ARS
03/23/2026 3:17 PM
CME Group (1156375) Filer
Form DEFA14A
03/23/2026 3:11 PM
CME Group (1156375) Filer
Form DEF 14A
03/23/2026 8:38 AM
CME Group (1156375) Issuer
Marcus Jonathan L (1952996) Reporting
Form 4/A
03/19/2026 8:47 AM
CME Group (1156375) Issuer
Marcus Jonathan L (1952996) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Cutinho Sunil (1619400) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Tobin Jack J (1638430) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Fitzpatrick Lynne (1915955) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Sammann Derek (1475318) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Winkler Julie (1692514) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Vroman Ken (1429863) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
DUFFY TERRENCE A (1212809) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Sprague Suzanne (1914409) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:23 AM
CME Group (1156375) Issuer
Piell Hilda Harris (1409789) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:24 AM
CME Group (1156375) Issuer
Marcus Jonathan L (1952996) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 11:24 AM
CME Group (1156375) Issuer
McCourt Timothy Francis (1917308) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 1:16 PM
CME Group (1156375) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2026 4:46 PM
CME Group (1156375) Issuer
Vroman Ken (1429863) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 4:48 PM
CME Group (1156375) Issuer
Tobin Jack J (1638430) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:43 PM
CME Group (1156375) Filer
Form DEFA14A
03/06/2026 3:13 PM
CME Group (1156375) Subject
Cook Elizabeth A (1643475) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 12:24 PM
CME Group (1156375) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
02/26/2026 4:30 PM
CME Group (1156375) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2026 3:46 PM
CME Group (1156375) Issuer
Durkin Bryan T (1341363) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:11 PM
CME Group (1156375) Subject
Durkin Bryan T (1341363) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2026 1:07 PM
CME Group (1156375) Issuer
GEPSMAN MARTIN J (1212813) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 11:15 AM
CME Group (1156375) Subject
GEPSMAN MARTIN J (1212813) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2026 12:03 PM
CME Group (1156375) Issuer
Suskind Dennis (1361519) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
CME Group (1156375) Subject
Suskind Dennis (1361519) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2026 6:06 AM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2026 8:31 AM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2026 1:28 PM
CME Group (1156375) Issuer
DUFFY TERRENCE A (1212809) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2026 1:30 PM
CME Group (1156375) Issuer
SHEPARD WILLIAM R (1212852) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2025 12:22 PM
CME Group (1156375) Subject
DUFFY TERRENCE A (1212809) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 3:09 PM
CME Group (1156375) Issuer
Sammann Derek (1475318) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 2:03 PM
CME Group (1156375) Subject
Sammann Derek (1475318) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 7:57 AM
CME Group (1156375) Issuer
Piell Hilda Harris (1409789) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2025 10:34 AM
CME Group (1156375) Issuer
Ford Harold Eugene Jr. (1799464) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2025 3:35 PM
CME Group (1156375) Subject
Ford Harold Eugene Jr. (1799464) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/24/2025 1:07 PM
CME Group (1156375) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2025 6:05 AM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 7:46 PM
CME Group (1156375) Issuer
SHEPARD WILLIAM R (1212852) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2025 6:30 PM
CME Group (1156375) Issuer
Marcus Jonathan L (1952996) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:44 PM
CME Group (1156375) Issuer
Piell Hilda Harris (1409789) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
DUFFY TERRENCE A (1212809) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
Sammann Derek (1475318) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
McCourt Timothy Francis (1917308) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
Dennis Michael G. (1811883) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
Tobin Jack J (1638430) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
Fitzpatrick Lynne (1915955) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:48 PM
CME Group (1156375) Issuer
Sprague Suzanne (1914409) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:49 PM
CME Group (1156375) Issuer
Marcus Jonathan L (1952996) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:49 PM
CME Group (1156375) Issuer
Vroman Ken (1429863) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:49 PM
CME Group (1156375) Issuer
Winkler Julie (1692514) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:49 PM
CME Group (1156375) Issuer
Cutinho Sunil (1619400) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025 11:06 AM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2025 3:06 PM
CME Group (1156375) Subject
Cutinho Sunil (1619400) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2025 7:01 PM
CME Group (1156375) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2025 6:08 AM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025 5:26 PM
CME Group (1156375) Issuer
SIEGEL HOWARD J (1212853) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:34 PM
CME Group (1156375) Issuer
GEPSMAN MARTIN J (1212813) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:34 PM
CME Group (1156375) Issuer
Hobert William W (1643402) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:34 PM
Carey Charles P (1341358) Reporting
CME Group (1156375) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:34 PM
CME Group (1156375) Issuer
Kaye Daniel G (1556974) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:34 PM
CME Group (1156375) Issuer
Durkin Bryan T (1341363) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:34 PM
CME Group (1156375) Issuer
Lucas Deborah J (1329150) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:35 PM
CME Group (1156375) Issuer
Lockett Phyllis M (1776684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:35 PM
CME Group (1156375) Issuer
Mulchrone Patrick J (1812174) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:35 PM
CME Group (1156375) Issuer
Seifu Rahael (1812194) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:35 PM
Bitsberger Timothy S. (1434852) Reporting
CME Group (1156375) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:35 PM
CME Group (1156375) Issuer
Cook Elizabeth A (1643475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:35 PM
CME Group (1156375) Issuer
Ford Harold Eugene Jr. (1799464) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:36 PM
CME Group (1156375) Issuer
Maloney Patrick W (1812087) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:11 PM
CME Group (1156375) Issuer
SHEPARD WILLIAM R (1212852) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:17 PM
CME Group (1156375) Issuer
Tierney Robert J JR (1776581) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:19 PM
Benesh Kathryn (1976318) Reporting
CME Group (1156375) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 5:23 PM
CME Group (1156375) Issuer
Suskind Dennis (1361519) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025 8:10 AM
Carey Charles P (1341358) Reporting
CME Group (1156375) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025 10:48 AM
Carey Charles P (1341358) Reporting
CME Group (1156375) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025 11:20 AM
CME Group (1156375) Issuer
Kaye Daniel G (1556974) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 2:43 PM
CME Group (1156375) Subject
Kaye Daniel G (1556974) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2025 12:43 PM
CME Group (1156375) Issuer
Marcus Jonathan L (1952996) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025 7:32 AM
CME Group (1156375) Issuer
Lockett Phyllis M (1776684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025 12:57 PM
CME Group (1156375) Subject
Lockett Phyllis M (1776684) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025 8:03 AM
Carey Charles P (1341358) Reporting
CME Group (1156375) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025 8:08 AM
CME Group (1156375) Issuer
GEPSMAN MARTIN J (1212813) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025 9:54 AM
Carey Charles P (1341358) Reporting
CME Group (1156375) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025 2:31 PM
CME Group (1156375) Subject
GEPSMAN MARTIN J (1212813) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025 12:06 PM
CME Group (1156375) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025 5:16 PM
CME Group (1156375) Issuer
Sammann Derek (1475318) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025 4:17 PM
CME Group (1156375) Issuer
Sammann Derek (1475318) Reporting
Form 4/A
(Data available from 1/1/2016 forward)

CME Group SEC Filings - Frequently Asked Questions

CME Group (CME) has submitted 855+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

CME Group's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on CME Group's financial statements page.

The most recent filing was a Form SCHEDULE 13G submitted on April 29, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:CME) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners